Chester County News and Community Website
LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) said its planned spin-off, NexGelRx, has secured strategic investments from Eric Gruntfest and Ariel Imas of Diesis Holdings, a move aimed at strengthening …
NEXGEL Spin-Off Draws Strategic Capital as NexGelRx Sharpens Focus Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) said it has spun off select drug delivery assets into a new entity, NexGelRx, a move designed to unlock value from its proprietary …
NEXGEL Spins Off Rx Unit, Locks In Royalties and Equity Without Dilution Read More LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) reported third quarter 2025 results showing stable revenue and improved margins as the hydrogel manufacturer continued to advance both its contract manufacturing and …
Hydrogel Innovator NEXGEL Posts Steady Q3 as Margin Gains Offset Flat Revenue Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL), a Pennsylvania-based innovator in hydrogel technology and advanced skincare solutions, announced it will release its financial results for the third quarter of 2025 …
NEXGEL to Announce Q3 2025 Results and Host Investor Call on November 11 Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) announced that Chief Executive Officer Adam Levy will present at the LD Micro Main Event XIX Conference, taking place October 19–21, 2025, at …
NEXGEL CEO to Present at LD Micro Main Event XIX Conference Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) posted second-quarter 2025 revenue of $2.88 million, up 100.3% from the same period last year, as demand for its branded products and contract …
NEXGEL Doubles Q2 Revenue, Targets $13M in 2025 With Positive EBITDA Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL), a leader in high-performance hydrogel technologies, has named Steve Ciardiello, CPA, to its Board of Directors, strengthening the company’s financial and governance capabilities as …
NEXGEL Appoints Shutterstock Executive Steve Ciardiello to Board of Directors Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) announced an expanded collaboration with European pharmaceutical and consumer health leader STADA Arzneimittel AG, aiming to bring a new suite of health products …
NEXGEL Expands Partnership With STADA, Secures $1 Million to Fuel New Product Launches Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: “NXGL”) announced that CEO Adam Levy will attend the 6th Annual CEO Networking Event hosted by Semco Capital in Chicago on Monday, June 2, …
NEXGEL CEO Adam Levy to Join 6th Annual Semco Capital Networking Event in Chicago Read More LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) announced substantial financial gains for the first quarter ending March 31, 2025, with revenue reaching $2.81 million. This marks a 121% increase year-over-year …
NEXGEL Reports 121% Revenue Growth in Q1 2025, Highlights Strong Momentum Read More